Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Goodkin

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
1H MRSI of normal appearing white matter in multiple sclerosisW D Rooney, D E Goodkin, N Schuff, et al.
Archives of Neurology|May 1, 1997
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosisD C Mohr, D E Goodkin, W Likosky, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2000
A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosisT L Luks, D E Goodkin, S J Nelson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 1996
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatmentD C Mohr, D E Goodkin, W Likosky, et al.
Archives of Neurology|October 16, 1999
Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosisD C Mohr, W Likosky, P Dwyer, et al.
Journal of Computer Assisted Tomography|September 1, 1992
Volume T1-weighted gradient echo MRI in multiple sclerosis patientsM Shah, J S Ross, C VanDyke, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 4, 1999
The psychosocial impact of multiple sclerosis: exploring the patient's perspectiveD C Mohr, L P Dick, D Russo, et al.
Neurology|April 1, 1995
Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI)W W Beatty, R H Paul, S L Wilbanks, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2003
MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophyD Pelletier, S J Nelson, J Oh, et al.
Archives of Neurology|August 1, 1991
Diagnostic criteria for multiple sclerosis research involving multiply affected familiesD E Goodkin, T H Doolittle, S S Hauser, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
1H MRSI of normal appearing white matter in multiple sclerosisW D Rooney, D E Goodkin, N Schuff, et al.
Archives of Neurology|May 1, 1997
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosisD C Mohr, D E Goodkin, W Likosky, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2000
A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosisT L Luks, D E Goodkin, S J Nelson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 1996
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatmentD C Mohr, D E Goodkin, W Likosky, et al.
Archives of Neurology|October 16, 1999
Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosisD C Mohr, W Likosky, P Dwyer, et al.
Journal of Computer Assisted Tomography|September 1, 1992
Volume T1-weighted gradient echo MRI in multiple sclerosis patientsM Shah, J S Ross, C VanDyke, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 4, 1999
The psychosocial impact of multiple sclerosis: exploring the patient's perspectiveD C Mohr, L P Dick, D Russo, et al.
Neurology|April 1, 1995
Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI)W W Beatty, R H Paul, S L Wilbanks, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2003
MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophyD Pelletier, S J Nelson, J Oh, et al.
Archives of Neurology|August 1, 1991
Diagnostic criteria for multiple sclerosis research involving multiply affected familiesD E Goodkin, T H Doolittle, S S Hauser, et al.
Pageof 9